Unique ID issued by UMIN | UMIN000032665 |
---|---|
Receipt number | R000037248 |
Scientific Title | The efficacy and the utility of switching into glucagon like peptide-1 receptor agonist plus basal insulin therapy in type 2 diabetic patients treated with Basal-Bolus therapy. |
Date of disclosure of the study information | 2018/05/21 |
Last modified on | 2019/05/22 17:15:33 |
The efficacy and the utility of switching into glucagon like peptide-1 receptor agonist plus basal insulin therapy in type 2 diabetic patients treated with Basal-Bolus therapy.
The efficacy and the utility of switching from basal-bolus therapy to GLP-1 RA plus basal insulin therapy.
The efficacy and the utility of switching into glucagon like peptide-1 receptor agonist plus basal insulin therapy in type 2 diabetic patients treated with Basal-Bolus therapy.
The efficacy and the utility of switching from basal-bolus therapy to GLP-1 RA plus basal insulin therapy.
Japan |
Type 2 diabetes
Endocrinology and Metabolism |
Others
NO
The efficacy and the utility
Efficacy
the characteristics of the patient who can successfully switch the treatment
efficacy(Diabetes treatment satisfaction questionnaire: DTSQ)
glycemic control(continuous glucose monitoring)
Urinary albumin concentration, Urinary L-FABP concentration
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
Medicine |
Change from prandial insulins to liraglutide
Change from liraglutide to duraglutide
20 | years-old | <= |
75 | years-old | > |
Male and Female
Type 2 diabetes.
The value of HbA1c less than 7.0% with basal-bolus insulin therapy without any oral anti-diabetics.
Sum of prandial insulin dose less than 24 units
Type 1 diabetes
with severe liver disease, severe renal disease or severe heart disease
with any carcinoma
under pregnancy
100
1st name | Fumitaka |
Middle name | |
Last name | Okajima |
Nippon Medical School Chiba-Hokusoh Hospital
Department of Endocrinology
270-1694
1715 Kamagari, Inzai, Chiba, Japan
0476-99-1111
okaji@nms.ac.jp
1st name | Fumitaka |
Middle name | |
Last name | Okajima |
Nippon Medical School Chiba-Hokusoh Hospital
Department of Endocrinology
270-1694
1715 Kamagari, Inzai, Chiba, Japan
0476-99-1111
okaji@nms.ac.jp
Department of Endocrinology, Nippon Medical School Chiba Hokusoh Hospital
Japan Society for The Promotion of Science
Government offices of other countries
Nippon Medical School Chiba-Hokusoh Hospital Institutional Review Board
1715 Kamakari, Inzai, Chiba, Japan
0476-99-1111
meiko-hirota@nms.ac.jp
NO
2018 | Year | 05 | Month | 21 | Day |
Unpublished
Open public recruiting
2017 | Year | 08 | Month | 24 | Day |
2017 | Year | 09 | Month | 15 | Day |
2017 | Year | 10 | Month | 01 | Day |
2019 | Year | 09 | Month | 30 | Day |
2018 | Year | 05 | Month | 21 | Day |
2019 | Year | 05 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037248
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |